NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 172 filers reported holding NOVAVAX INC in Q4 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | -18.2% | 4,900 | -16.9% | 0.00% | – |
| Q3 2018 | $11,000 | +22.2% | 5,900 | -10.4% | 0.00% | – |
| Q2 2018 | $9,000 | +50.0% | 6,585 | +46.8% | 0.00% | – |
| Q1 2018 | $6,000 | 0.0% | 4,485 | 0.0% | 0.00% | – |
| Q4 2017 | $6,000 | -64.7% | 4,485 | -70.0% | 0.00% | -100.0% |
| Q3 2017 | $17,000 | 0.0% | 14,960 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $17,000 | -63.0% | 14,960 | -57.9% | 0.00% | -50.0% |
| Q1 2017 | $46,000 | 0.0% | 35,550 | -3.7% | 0.00% | 0.0% |
| Q4 2016 | $46,000 | -45.9% | 36,900 | -9.9% | 0.00% | -50.0% |
| Q3 2016 | $85,000 | -65.2% | 40,950 | +22.2% | 0.00% | -71.4% |
| Q2 2016 | $244,000 | +4.7% | 33,500 | +20.4% | 0.01% | -12.5% |
| Q4 2015 | $233,000 | – | 27,816 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
| BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
| Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
| HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
| WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
| Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
| AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
| Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
| Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |